Based on accumulating evidence, P-gp plays a critical role in refractory epilepsy because most of the commonly used AEDs are substrates of P-gp, resulting in therapeutic failure in patients with epilepsy by limiting drug delivery to epileptogenic brain regions. This evidence concerns the gene PGP and epilepsy.